Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Pilot Translation Study of Neoadjuvant Fulvestrant Plus Palbociclib in Women With Advanced Low Grade Serous Carcinoma

Trial Profile

Pilot Translation Study of Neoadjuvant Fulvestrant Plus Palbociclib in Women With Advanced Low Grade Serous Carcinoma

Not yet recruiting
Phase of Trial: Phase II

Latest Information Update: 19 Dec 2018

At a glance

  • Drugs Fulvestrant (Primary) ; Palbociclib (Primary)
  • Indications Carcinoma; Fallopian tube cancer; Ovarian cancer; Peritoneal cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 11 Dec 2018 Planned initiation date changed from 1 Nov 2018 to 1 Jan 2019.
    • 02 Oct 2018 Planned initiation date changed from 1 Sep 2018 to 1 Nov 2018.
    • 11 Jul 2018 Planned initiation date changed from 1 Aug 2018 to 1 Sep 2018.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top